Navigation Links
Sorrento Therapeutics and Ben-Gurion University Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
Date:7/9/2013

hose set forth in this press release due to the risks and uncertainties inherent in Sorrento's businesses; the scope and validity of patent protection for Sorrento's platform technologies, and the risk that the development or commercialization of product candidates may infringe the intellectual property rights of others; the potential that Sorrento may require substantial additional funding in order to obtain regulatory approval for and commercialize Sorrento's proprietary G-MAB® fully-human antibody library platform technologies or product candidates; and additional risks set forth in Sorrento's  filings with the Securities and Exchange Commission. These forward-looking statements represent Sorrento's judgment as of the date of this release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Sorrento undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.  This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

[1] BioMedTracker, DataMonitor, 2013.
[2] Pyenson B, Fitch K, and Iwasaki K. Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease. Milliman, Inc. May 2009
[3] Centers for Disease Control and Prevention. Hepatitis C Fact Sheet: CDC Viral Hepatitis. Available at: http://www.cdc.gov/hepatitis/HCV/PDFs/HepCGeneralFactSheet.pdf Updated June 2010.
[4] Volk MI, Tocco R, Saini S,
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Awarded Third Phase I STTR Grant
2. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
3. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
6. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
7. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
8. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
9. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
10. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
11. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... -- Bob Pack, who lost his two young children to ... Association to immediately cease airing a television ad from ... News called "shamelessly deceptive" and of which the LA ... about the measure is wrong." The ... doctors check California,s existing statewide ...
(Date:9/29/2014)... 2014 Dynatronics Corporation (NASDAQ: ... investors today at 2:00 p.m. ET to discuss ... June 30, 2014.  The corrected call-in number for ... Dynatronics manufactures, markets and distributes advanced-technology medical ... and rehabilitation equipment for the physical therapy, sports ...
(Date:9/29/2014)... BOGOTA, Colombia , Sept. 29, 2014 /PRNewswire/ ... has announced a promising new drug treatment: ... 3-bromopyruvate (3-BrPA) that has already proven successful at ... medical researchers behind this novel treatment are optimistic ... patients who have exhausted current therapeutic avenues. ...
Breaking Medicine Technology:Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 2Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 3
... Reportlinker.com announces that a new ... its catalogue: External ... Russia, India, China, South Africa) to ... External Defibrillator Market ...
... Orthopedic Group, Inc. today announced the appointment of Vinit ... immediately.  Mr. Asar joined the company in December 2008 ... nearly 20 years of global business operations experience in ... his new position, Mr. Asar will continue to lead ...
Cached Medicine Technology:External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 16External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 17External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 18External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 19Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer 2Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer 3
(Date:9/30/2014)... 2014 In honor of National Breast ... and their courageous battles, Incredible Veins, Body & Skin ... PicoSure® by Cynosure. , “For cancer patients who ... is applied on their skin to accurately aim the ... “For many survivors, they decide to have their tattoo ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 In ... well as better data capture and management functions ... ClinCapture electronic data capture (EDC) system. ClinCapture offers ... ability to easily manage clinical trial data and ... cement Synergy’s position as the leading clinical research ...
(Date:9/30/2014)... high-dose vitamin D3 compared with placebo did not reduce ... of stay, hospital mortality, or the risk of death ... who were critically ill, according to a study published ... early online to coincide with its presentation at the ... , A high prevalence of low vitamin D levels ...
(Date:9/30/2014)... Delhi, India (PRWEB) September 30, 2014 RBS ... reputation management service named ‘Remove Your Name’. , The ... being asked reason behind giving the service this odd name, ... there is nothing odd in this name. We have named ... as well as organizations to get rid of all those ...
(Date:9/30/2014)... Massachusetts (PRWEB) September 30, 2014 ... Wingate of East Longmeadow facility has officially announced ... Ventilator Program that combines advanced medical technology ... program is one of the only non-hospital options ... of care. The primary focus of this ...
Breaking Medicine News(10 mins):Health News:Incredible Veins, Body & Skin Takes A Stand Against Breast Cancer With PicoSure® By Cynosure 2Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes 2Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 3
... activities and may make men smarter by enabling them ... study.// ,Researchers studied the effects of fatherhood ... that spend 70 percent of their time caring for ... time, according to new research by Princeton University psychologist ...
... people are hit harder by hangover while teenagers have a ... ,US psychologist Elena Varlinskaya and other researchers studied the effects ... teenagers and adults. , ,The rats - chosen because ... with alcohol and their movements monitored, reported the online edition ...
... personnel returning from vacation, the Central Reserve Police Force (CRPF) ... ,"We have found that over 80 percent of ... personnel who had returned from leave," said a CRPF official ... official added that the trend was mostly sighted in Delhi, ...
... pain and disc disorder now have a reason to ... results than conventional// surgery. ,Ozonucleolysis, as the ... western countries, according to senior doctors who are here ... ozone discectomy for curing spinal injury is a better ...
... in Chennai attracted a visitor from the Safari country ... osteoarthritis of both knees underwent bilateral// knee replacements here ... Orthopedic surgeon remarked that this was the first time ... for bilateral knee replacements. His son, a UK based ...
... research findings show men have fewer long-term gastrointestinal ... with three-dimensional// conformal radiation therapy (3D CRT) for ... radiation used in the IMRT group. These and ... presented today at the 48th Annual Meeting of ...
Cached Medicine News:Health News:Older People Get Worse Hangovers 2Health News:CRPF To Issue Contraceptives To Fight AIDS 2Health News:Ozone Treatment - A Good Alternative For Spinal Injury 2Health News:IMRT Versus 3D CRT For Prostate Cancer, New Long-Term Data Assesses Side Effects 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: